Table 4.
Factors | Overall survival | Disease-free survival | ||||
---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||
p | HR (95% CI) | p | p | HR (95% CI) | p | |
Age (≥ 60 years) | < 0.001 | 2.225 (1.723–2.873) | < 0.001 | 0.007 | 1.458 (1.149–1.852) | 0.002 |
Male | 0.378 | 0.205 | ||||
BMI (≥ 25) | 0.289 | 0.515 | ||||
ASA score 3–4 | 0.617 | 0.373 | ||||
Adjuvant CTx | < 0.001 | 0.816 (0.648–1.027) | 0.083 | 0.637 | ||
Retrieved LNs ≥ 12 | 0.149 | 0.425 | ||||
Open approach | < 0.001 | 3.920 (2.754–5.580) | < 0.001 | 0.001 | 1.726 (1.344–2.216) | < 0.001 |
Transfusion (+) | 0.382 | 0.039 | 2.280 (1.513–3.436) | < 0.001 | ||
TNM stage III | < 0.001 | 2.975 (2.355–3.757) | < 0.001 | < 0.001 | 3.918 (3.064–5.012) | < 0.001 |
Lymphatic invasion | 0.010 | 2.457 (1.385–4.360) | < 0.001 | 2.942 (2.334–3.708) | < 0.001 | |
Perineural invasion | 0.293 | 0.002 | 2.657 (1.965–3.593) | < 0.001 | ||
Vascular invasion | 0.002 | 2.967 (2.237–3.935) | < 0.001 | 0.004 | 3.346 (2.537–4.412) | < 0.001 |